Contineum Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in San Diego, California, focused on developing innovative oral small molecule therapies to address critical unmet needs in neuroscience, inflammation, and immunology. The company boasts a robust pipeline driven by advanced research and a dedication to scientific excellence, positioning it as a leader in delivering groundbreaking therapeutic solutions aimed at enhancing patient outcomes. With a strategic focus on addressing pressing healthcare challenges, Contineum is poised for significant growth in the biopharmaceutical sector, making it an attractive investment opportunity for institutional investors seeking to participate in transformative healthcare advancements. Show more

Location: 3565 GENERAL ATOMICS COURT, SAN DIEGO, CA, UNITED STATES, 92121, San Diego, CA, 92121, USA | Website: https://www.contineum-tx.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

520.9M

52 Wk Range

$3.35 - $14.94

Previous Close

$14.60

Open

$14.40

Volume

555,275

Day Range

$13.58 - $14.94

Enterprise Value

356.4M

Cash

42.63M

Avg Qtr Burn

-12.2M

Insider Ownership

1.14%

Institutional Own.

59.59%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
PIPE-307 Details Relapsing-remitting multiple sclerosis (RRMS)	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PIPE-307 (M1 Receptor Inhibitor) Details Major Depressive Disorder (MDD)	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PIPE-791 Details Idiopathic pulmonary fibrosis (IPF)	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PIPE-791 Details Osteoarthritis (OA) and low back pain (LBP)	Phase 1b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PIPE-791 Details Neuroscience, Inflammation and Immunology (NI&I) Indications	Phase 1b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.